PNPLA8 Antikörper (AA 158-345) (HRP)
Kurzübersicht für PNPLA8 Antikörper (AA 158-345) (HRP) (ABIN7146395)
Target
Alle PNPLA8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 158-345
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Calcium-independent phospholipase A2-gamma protein (158-345AA)
-
Isotyp
- IgG
-
-
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (AA 158-345) antibody
PNPLA8 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (AA 212-240), (N-Term) antibodyPNPLA8 Reaktivität: Human WB, FACS Wirt: Kaninchen Polyclonal RB24901 unconjugated
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (C-Term) antibodyPNPLA8 Reaktivität: Human, Maus, Ratte ELISA, WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (C-Term) antibodyPNPLA8 Reaktivität: Human ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (C-Term) antibodyPNPLA8 Reaktivität: Human, Maus ELISA, WB Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (AA 359-408) antibodyPNPLA8 Reaktivität: Human, Maus, Ratte, Kaninchen, Affe, Rind (Kuh), Hund, Meerschweinchen, Pferd, Fledermaus, Hamster, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (Middle Region) antibodyPNPLA8 Reaktivität: Human, Maus, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
anti-Patatin-Like phospholipase Domain Containing 8 (PNPLA8) (Middle Region) antibodyPNPLA8 Reaktivität: Human, Maus, Ratte, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))
-
Andere Bezeichnung
- PNPLA8
-
Hintergrund
-
Background: Calcium-independent phospholipase A2, which catalyzes the hydrolysis of the sn-2 position of glycerophospholipids, PtdSer and to a lower extent PtdCho. Cleaves membrane phospholipids.
Aliases: Calcium-independent phospholipase A2-gamma antibody, Intracellular membrane associated calcium independent phospholipase A2 gamma antibody, Intracellular membrane-associated calcium-independent phospholipase A2 gamma antibody, IPLA2 2 antibody, iPLA2 gamma antibody, IPLA2(GAMMA) antibody, iPLA2-2 antibody, iPLA2-gamma antibody, IPLA22 antibody, IPLA2G antibody, Patatin like phospholipase domain containing protein 8 antibody, Patatin-like phospholipase domain-containing protein 8 antibody, PLPL8_HUMAN antibody, PNPLA-gamma antibody, PNPLA8 antibody
-
UniProt
- Q9NP80
Target
-
